Thomas M. Cunningham

Array ( [id] => 3810996 [patent_doc_number] => 05770201 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'HA-2 antigenic peptide' [patent_app_type] => 1 [patent_app_number] => 8/363691 [patent_app_country] => US [patent_app_date] => 1994-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5846 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770201.pdf [firstpage_image] =>[orig_patent_app_number] => 363691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730720 [patent_doc_number] => 05652342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same' [patent_app_type] => 1 [patent_app_number] => 8/354751 [patent_app_country] => US [patent_app_date] => 1994-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17176 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652342.pdf [firstpage_image] =>[orig_patent_app_number] => 354751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3870425 [patent_doc_number] => 05747048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates' [patent_app_type] => 1 [patent_app_number] => 8/354157 [patent_app_country] => US [patent_app_date] => 1994-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 16133 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747048.pdf [firstpage_image] =>[orig_patent_app_number] => 354157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729064 [patent_doc_number] => 05635357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Stabilized microspheres and methods of preparation' [patent_app_type] => 1 [patent_app_number] => 8/343313 [patent_app_country] => US [patent_app_date] => 1994-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6394 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635357.pdf [firstpage_image] =>[orig_patent_app_number] => 343313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080479 [patent_doc_number] => 06024966 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Gene encoding protein antigens of plasmodium falciparum and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/335204 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 9 [patent_no_of_words] => 8492 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/024/06024966.pdf [firstpage_image] =>[orig_patent_app_number] => 335204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3555966 [patent_doc_number] => 05500215 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-19 [patent_title] => 'Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones' [patent_app_type] => 1 [patent_app_number] => 8/334357 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 7653 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/500/05500215.pdf [firstpage_image] =>[orig_patent_app_number] => 334357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059552 [patent_doc_number] => 06007815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Anti-idiotype vaccination against diseases resulting from pathogenic responses by specific T cell populations' [patent_app_type] => 1 [patent_app_number] => 8/332428 [patent_app_country] => US [patent_app_date] => 1994-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3799 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007815.pdf [firstpage_image] =>[orig_patent_app_number] => 332428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689379 [patent_doc_number] => 05679347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods' [patent_app_type] => 1 [patent_app_number] => 8/322980 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 55 [patent_no_of_words] => 21173 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679347.pdf [firstpage_image] =>[orig_patent_app_number] => 322980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3800571 [patent_doc_number] => 05853737 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Method for inducing a CD1-restricted immune response' [patent_app_type] => 1 [patent_app_number] => 8/322979 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 55 [patent_no_of_words] => 21150 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853737.pdf [firstpage_image] =>[orig_patent_app_number] => 322979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833301 [patent_doc_number] => 05814617 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Protective 17 KDA malaria hepatic and erythrocytic stage immunogen and gene' [patent_app_type] => 1 [patent_app_number] => 8/319704 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 13817 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814617.pdf [firstpage_image] =>[orig_patent_app_number] => 319704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3754364 [patent_doc_number] => 05720959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Malaria vaccine' [patent_app_type] => 1 [patent_app_number] => 8/290919 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7013 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/720/05720959.pdf [firstpage_image] =>[orig_patent_app_number] => 290919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098627 [patent_doc_number] => 06051231 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Antiviral methods and prepations' [patent_app_type] => 1 [patent_app_number] => 8/316382 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6111 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051231.pdf [firstpage_image] =>[orig_patent_app_number] => 316382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3608574 [patent_doc_number] => 05589453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Human rhinovirus receptor protein (ICAM-1) that inhibits rhinovirus attachment and infectivity' [patent_app_type] => 1 [patent_app_number] => 8/316383 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3538 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589453.pdf [firstpage_image] =>[orig_patent_app_number] => 316383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828673 [patent_doc_number] => 05814307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6' [patent_app_type] => 1 [patent_app_number] => 8/312205 [patent_app_country] => US [patent_app_date] => 1994-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8178 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814307.pdf [firstpage_image] =>[orig_patent_app_number] => 312205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3870942 [patent_doc_number] => 05837812 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/308952 [patent_app_country] => US [patent_app_date] => 1994-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7490 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837812.pdf [firstpage_image] =>[orig_patent_app_number] => 308952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3788220 [patent_doc_number] => 05725857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Immunotoxin with in vivo T cell suppressant activity and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/308730 [patent_app_country] => US [patent_app_date] => 1994-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8893 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/725/05725857.pdf [firstpage_image] =>[orig_patent_app_number] => 308730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781531 [patent_doc_number] => 05736142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Alteration of immune response using pan DR-binding peptides' [patent_app_type] => 1 [patent_app_number] => 8/305871 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 14 [patent_no_of_words] => 17330 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736142.pdf [firstpage_image] =>[orig_patent_app_number] => 305871 [rel_patent_id] =>[rel_patent_doc_number] =>)